论文信息 - The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease - 字舞流文

The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease

R. Christopherson | O. G. Best | S. Mulligan | Nisha Singh | Yiping Che | C. Forsyth | Richard I. Christopherson | Stephen P. Mulligan